Latest Genetic Engineering Jobs

Director, AI/ML MIDD Oncology Clinical Pharmacology, Modeling and Simulation

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within a matrixed Clinical Pharmacology Modelling and Simulation group working across small molecules, biologics and antibody drug conjugates.

GSK Durham, United States US$188,100 – US$313,500 pa

Hybrid

Director, Real World Data Platform and Portfolio Lead

Accountable for the strategic execution and coordination of internal and external Real World Data platform partnerships, ensuring maximum scientific value from RWD across R&D and portfolio activities. Leads above-therapy-area data partnerships, informs data linkage and governance strategy, and partners with engineering, AI and DevOps teams on pipeline and infrastructure. Distinct for its global, cross-functional scope spanning translational sciences, medical affairs and commercial functions.

GSK USA - Pennsylvania - Upper Providence

Sr. Manager, Site Budgets and Contracts

This role involves leading the creation and management of investigator site budgets and contracts for global clinical trials, using Grants Manager and FMV benchmarking tools. The Senior Manager collaborates with CROs, Legal, and Clinical Operations to ensure site budgets align with study forecasts and are executed on time. Responsibilities include strategic planning, contract negotiation oversight, risk identification, and process improvement within an outsourced trial model.

Moderna Clinical Development

Hybrid Permanent

Sr. Research Associate, Bioanalytical & Molecular Assays - Ligand Binding Assays

Develop, validate and run ligand-binding and cell-based bioanalytical assays generating pharmacodynamic and immunogenicity data for clinical mRNA programmes. Testing clinical samples in a GcLP-regulated lab using Thermo Watson LIMS, with documentation, SOPs and validation reports, partnering with Clinical Operations and Sample Management.

Moderna Clinical Development

Hybrid Permanent

Principal Medical Writer

Lead authoring and strategic planning for clinical and regulatory documents, including protocols, clinical study reports, briefing documents and submission dossiers. Manages end-to-end writing projects, coordinating contributors, timelines and quality checks, and acts as subject matter expert on medical writing standards, CTD structure and regulatory expectations while driving process improvement and audit readiness.

GSK Durham, United States

Principal Medical Writer

Lead authoring and strategic planning of clinical and regulatory documents such as protocols, clinical study reports, briefing documents and CTD submission dossiers. Manage end-to-end writing projects, coordinating contributors, timelines and quality checks, and act as subject matter expert on medical writing standards and regulatory expectations while driving process improvement and audit readiness.

GSK London

Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

Leads the design and execution of real-world evidence and health outcomes studies for oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing. Requires close collaboration across a matrix and deep knowledge of real-world data sources and payer needs.

GSK Waltham, United States US$204,000 – US$340,000 pa

Hybrid

Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

Leads the design and execution of real-world evidence and health outcomes studies across oncology assets, managing timelines, budgets and quality of protocols, analyses and publications. Advises internal medical, market access and commercial teams and external experts on evidence strategy for HTA submissions, reimbursement and value-based pricing, while building knowledge of real-world data sources and payer needs.

GSK London US$204,000 – US$340,000 pa

Hybrid

Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

Leads the design and delivery of real-world evidence and health outcomes studies across oncology assets, managing protocols, budgets, timelines and vendor deliverables. Partners with medical, market access, R&D and commercial teams plus external experts to shape evidence for HTA submissions, reimbursement and value-based pricing. Requires deep knowledge of RWD sources and payer evidence requirements.

GSK Rockville, United States US$204,000 – US$340,000 pa

Hybrid

Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology

Leads the design and delivery of real-world evidence and health outcomes studies for oncology assets, managing protocols, budgets, vendors and reporting from concept to publication. Advises medical, market access and commercial teams on payer and HTA evidence needs, and builds relationships with external experts and data partners.

GSK Durham, United States US$204,000 – US$340,000 pa

Hybrid

Senior Medical Director, Oncology Clinical Development - Lung

Senior physician leader providing medical oversight, safety monitoring and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional matrix teams on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence at least two days a week at a GSK site in Switzerland, the UK or the US.

GSK Waltham, United States US$242,550 – US$404,250 pa

On-site

Senior Medical Director, Oncology Clinical Development - Lung

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires deep lung cancer drug development expertise including early phase trials.

GSK Stevenage US$242,550 – US$404,250 pa

On-site

Senior Medical Director, Oncology Clinical Development - Lung

Senior physician leader providing medical oversight, safety evaluation and clinical data interpretation across lung cancer studies within a clinical programme team. Partners with the Senior Scientist and cross-functional groups on protocol design, regulatory interactions and external scientific engagement, while mentoring Medical Directors. Requires an on-site presence of at least two days a week at a GSK site.

GSK Zug, Switzerland US$242,550 – US$404,250 pa

On-site

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician on oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation across Phase I–III studies. Partners with a Senior Scientist and cross-functional matrix teams on protocol development, regulatory interactions and investigator engagement, with on-site presence 2–3 days per week.

GSK Waltham, United States US$222,750 – US$371,250 pa

Hybrid

Medical Director, Oncology Clinical Development - Lung & Head/Neck Cancers

Serves as the physician within oncology clinical programme teams for lung and head/neck cancers, leading medical monitoring, safety oversight and clinical data interpretation. Partners with the Senior Scientist and cross-functional Clinical Matrix Team on protocol development, regulatory interactions and investigator engagement, with on-site presence 2-3 days per week.

GSK Stevenage US$222,750 – US$371,250 pa

On-site